Wildcat Capital Management, LLC — 13F Holdings & Portfolio

CIK 1582384 · latest 13F-HR filed 2026-07-22

Wildcat Capital Management, LLC manages $228.5M in 13F-reported U.S. long-equity assets across 3 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are ULCC (97.13%), ALLO (2.66%), CHYM (0.21%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 1 new position, exited 0, added to 1, and trimmed 1.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
888 SEVENTH AVENUE
37TH FLOOR
NEW YORK, NY 10106
Phone
(212) 468-5100
Filing Manager
Wildcat Capital Management, LLC
NEW YORK, NY
Signatory
Brian J. Rosenblatt
General Counsel and Chief Operating Officer
Loading holdings…
AUM

$228.5M

Long-equity book

Holdings

3

Distinct positions

Period

2026-06-30

Filed 2026-07-22

Q/Q Activity

+1 / −0 / ↑1 / ↓1

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • FRONTIER GROUP HLDGS INC$122.9M +124.1%
Show all 1

Top Trims

  • ALLOGENE THERAPEUTICS INC-$1.1M -14.8%
Show all 1

New Positions

  • CHIME FINL INC$488.9K
Show all 1

Exited Positions

  • No exits this quarter.
Show all 0
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 FRONTIER GROUP HLDGS INC ULCC 35909R108 $222.0M 97.13% 28,061,351 SH
2 ALLOGENE THERAPEUTICS INC ALLO 019770106 $6.1M 2.66% 2,920,787 SH
3 CHIME FINL INC CHYM 16935C109 $488.9K 0.21% 23,874 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-07-22 $228.5M 3 0001999371-26-015582
2026-03-31 2026-05-01 $106.2M 2 0001999371-26-009738
2025-12-31 2026-02-03 $136.5M 3 0001999371-26-002481